Country: Jordan
Language: English
Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Sodium Valproate 57.64 mg/ml
شركة ألفه للأدوية - Ulfa Pharma Co.
N03AG01
Sodium Valproate 57.64 mg/ml
57.64 mg/ml
150 ml
Unither Liquid Manufacturing (فرنسا)
3.58 :سعر الجمهور + الضريبة
16/05/2016 4:02 PM - VISTAlink folder 1907488 - Page 3/8 WHAT IS IN THIS LEAFLET : 1. What Depakine and what it is used for 2. What you need to know before you take Depakine 3. How to take Depakine 4. Possible side effects 5. How to store Depakine 6. Further Information. 1. WHAT DEPAKINE IS AND WHAT IT IS USED TO Depakine belongs to a family of medicines called antiepileptics. This medicine is used to treat various types of seizures in adults and children. It is also used in children to prevent fever-related seizures. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DEPAKINE CONTRAINDICATIONS: NEVER TAKE DEPAKINE: - if you are allergic to the active substance of this medicine (sodium valproate) or to any of the other ingredients in Depakine. For the list of ingredients, see Section 6, - if you are allergic to a medicine in the same family as valproate (divalproate, valpromide), - if you have liver disease (acute or chronic hepatitis), - if you or a member of your family have ever had serious liver disease, particularly related to use of a medicine, - if you have hepatic porphyria (hereditary liver disease), - if you have a genetic problem causing a mitochondrial disorder (e.g. Alpers-Huttenlocher syndrome), - if you are currently taking the following medicines: • mefloquine (medicine used to treat malaria), • St. John’s Wort (plant used to treat depression). If your doctor has informed you that you have an intolerance to certain sugars, contact him or her before taking this medicine. APPROPRIATE PRECAUTIONS FOR USE; SPECIAL WARNING This medicine can, in very rare cases, cause liver damage (hepatitis) or pancreas damage (pancreatitis), which can be serious and life-threatening. Your doctor will prescribe blood tests to regularly monitor your liver function, particularly during the first 6 months of treatment. Inform your doctor immediately if any of the following signs appear: - sudden fatigue, loss of appetite, exhaustion, drowsiness, swelling of the legs, general malaise, - repeated vomiting, nausea, stomach or bo Read the complete document